CHAPTER 1. Industry Overview of Anti-Rheumatics Market
1.1. Definition and Scope
1.1.1. Definition of Anti-Rheumatics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Anti-Rheumatics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Anti-Rheumatics Market By Drug Class
1.2.3. Anti-Rheumatics Market By Type
1.2.4. Anti-Rheumatics Market By Distribution Channel
1.2.5. Anti-Rheumatics Market By End-User
1.2.6. Anti-Rheumatics Market By Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Anti-Rheumatics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Anti-Rheumatics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Anti-Rheumatics Market By Drug Class
4.1. Introduction
4.2. Anti-Rheumatics Market Revenue (USD Billion) By Drug Class
4.2.1. Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
4.2.2. Nonsteroidal Anti-inflammatory Drugs (NSAID’S)
4.2.2.1. Nonsteroidal Anti-inflammatory Drugs (NSAID’S) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Disease Modifying Anti-rheumatics Drugs (DMARD’S)
4.2.3.1. Disease Modifying Anti-rheumatics Drugs (DMARD’S) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.4. Corticosteroids
4.2.4.1. Corticosteroids Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.5. Uric Acid Drugs
4.2.5.1. Uric Acid Drugs Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.6. Others
4.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Anti-Rheumatics Market By Type
5.1. Introduction
5.2. Anti-Rheumatics Market Revenue (USD Billion) By Type
5.2.1. Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
5.2.2. Over-the-counter Drugs
5.2.2.1. Over-the-counter Drugs Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Prescription-based Drugs
5.2.3.1. Prescription-based Drugs Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Anti-Rheumatics Market By Distribution Channel
6.1. Introduction
6.2. Anti-Rheumatics Market Revenue (USD Billion) By Distribution Channel
6.2.1. Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
6.2.2. Hospital Pharmacies
6.2.2.1. Hospital Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Retail Pharmacies
6.2.3.1. Retail Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Online Pharmacies
6.2.4.1. Online Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. Anti-Rheumatics Market By End-User
7.1. Introduction
7.2. Anti-Rheumatics Market Revenue (USD Billion) By End-User
7.2.1. Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
7.2.2. Hospitals & Clinics
7.2.2.1. Hospitals & Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.3. Ambulatory Surgical Centers
7.2.3.1. Ambulatory Surgical Centers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.4. Healthcare Specialty Process
7.2.4.1. Healthcare Specialty Process Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 8. North America Anti-Rheumatics Market By Country
8.1. North America Anti-Rheumatics Market Overview
8.2. U.S.
8.2.1. U.S. Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
8.2.2. U.S. Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
8.2.3. U.S. Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
8.2.4. U.S. Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.3. Canada
8.3.1. Canada Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
8.3.2. Canada Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
8.3.3. Canada Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
8.3.4. Canada Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.4. North America PEST Analysis
CHAPTER 9. Europe Anti-Rheumatics Market By Country
9.1. Europe Anti-Rheumatics Market Overview
9.2. U.K.
9.2.1. U.K. Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
9.2.2. U.K. Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
9.2.3. U.K. Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
9.2.4. U.K. Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.3. Germany
9.3.1. Germany Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
9.3.2. Germany Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
9.3.3. Germany Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
9.3.4. Germany Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.4. France
9.4.1. France Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
9.4.2. France Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
9.4.3. France Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
9.4.4. France Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.5. Spain
9.5.1. Spain Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
9.5.2. Spain Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
9.5.3. Spain Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
9.5.4. Spain Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.6. Rest of Europe
9.6.1. Rest of Europe Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
9.6.2. Rest of Europe Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
9.6.3. Rest of Europe Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
9.6.4. Rest of Europe Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Anti-Rheumatics Market By Country
10.1. Asia Pacific Anti-Rheumatics Market Overview
10.2. China
10.2.1. China Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
10.2.2. China Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
10.2.3. China Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.2.4. China Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.3. Japan
10.3.1. Japan Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
10.3.2. Japan Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
10.3.3. Japan Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.3.4. Japan Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.4. India
10.4.1. India Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.4.2. India Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
10.4.3. India Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.4.4. India Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.5. Australia
10.5.1. Australia Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
10.5.2. Australia Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
10.5.3. Australia Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.5.4. Australia Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.6. South Korea
10.6.1. South Korea Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
10.6.2. South Korea Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
10.6.3. South Korea Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.6.4. South Korea Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
10.7.2. Rest of Asia-Pacific Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
10.7.3. Rest of Asia-Pacific Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.7.4. Rest of Asia-Pacific Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Anti-Rheumatics Market By Country
11.1. Latin America Anti-Rheumatics Market Overview
11.2. Brazil
11.2.1. Brazil Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
11.2.2. Brazil Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
11.2.3. Brazil Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.2.4. Brazil Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.3. Mexico
11.3.1. Mexico Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
11.3.2. Mexico Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
11.3.3. Mexico Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.3.4. Mexico Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.4. Rest of Latin America
11.4.1. Rest of Latin America Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
11.4.2. Rest of Latin America Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
11.4.3. Rest of Latin America Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.4.4. Rest of Latin America Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
CHAPTER 12. Middle East & Africa Anti-Rheumatics Market Overview
12.1. GCC
12.1.1. GCC Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
12.1.2. GCC Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
12.1.3. GCC Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.1.4. GCC Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
12.2. South Africa
12.2.1. South Africa Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
12.2.2. South Africa Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
12.2.3. South Africa Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.2.4. South Africa Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
12.3. Rest of Middle East & Africa
12.3.1. Rest of Middle East & Africa Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
12.3.2. Rest of Middle East & Africa Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Type, 2018-2030
12.3.3. Rest of Middle East & Africa Anti-Rheumatics Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.3.4. Rest of Middle East & Africa Anti-Rheumatics Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
12.4. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Anti-Rheumatics Market
13.1. Anti-Rheumatics Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investments
13.2.2. Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Anti-Rheumatics market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements
CHAPTER 14. Company Profile
14.1. Amgen Inc.
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2021
14.1.3.2. Amgen Inc. 2021 Anti-Rheumatics Business Regional Analysis
14.1.4. Product / Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Biogen Inc.
14.3. Bristol-Myers Squibb Company
14.4. Celegene Corporations
14.5. Celltrion Inc.
14.6. F. Hoffmann-La Roche Ltd.
14.7. Johnson & Johnson
14.8. MedImmune, LLC
14.9. Pfizer, Inc.
14.10. Takeda Pharmaceutical Company Ltd.